Standard
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. / Eugen-Olsen, J; Andersen, O; Linneberg, A; Ladelund, S; Hansen T, W; Langkilde, A; Petersen, Janne; Pielak, T; Møller, N. L.; Jeppesen, J; Lyngbæk, S; Fenger, M; Olsen M, H; Borch-Johnsen, K; Jørgensen, Torben; Haugaard S, B; Hildebrandt, P. R. .
I:
Journal of Internal Medicine, Bind 268, Nr. 3, 2010, s. 296-308.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Eugen-Olsen, J
, Andersen, O, Linneberg, A, Ladelund, S
, Hansen T, W, Langkilde, A
, Petersen, J, Pielak, T, Møller, NL, Jeppesen, J, Lyngbæk, S, Fenger, M, Olsen M, H, Borch-Johnsen, K, Jørgensen, T
, Haugaard S, B & Hildebrandt, PR 2010, '
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population',
Journal of Internal Medicine, bind 268, nr. 3, s. 296-308.
https://doi.org/10.1111/j.1365-2796.2010.02252.xAPA
Eugen-Olsen, J.
, Andersen, O., Linneberg, A., Ladelund, S.
, Hansen T, W., Langkilde, A.
, Petersen, J., Pielak, T., Møller, N. L., Jeppesen, J., Lyngbæk, S., Fenger, M., Olsen M, H., Borch-Johnsen, K., Jørgensen, T.
, Haugaard S, B., & Hildebrandt, P. R. (2010).
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
Journal of Internal Medicine,
268(3), 296-308.
https://doi.org/10.1111/j.1365-2796.2010.02252.xVancouver
Eugen-Olsen J
, Andersen O, Linneberg A, Ladelund S
, Hansen T W, Langkilde A o.a.
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
Journal of Internal Medicine. 2010;268(3):296-308.
https://doi.org/10.1111/j.1365-2796.2010.02252.xAuthor
Eugen-Olsen, J ; Andersen, O ; Linneberg, A ; Ladelund, S ; Hansen T, W ; Langkilde, A ; Petersen, Janne ; Pielak, T ; Møller, N. L. ; Jeppesen, J ; Lyngbæk, S ; Fenger, M ; Olsen M, H ; Borch-Johnsen, K ; Jørgensen, Torben ; Haugaard S, B ; Hildebrandt, P. R. . / Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. I: Journal of Internal Medicine. 2010 ; Bind 268, Nr. 3. s. 296-308.
Bibtex
@article{e42aac368c014591837e8d090ad38194,
title = "Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population",
abstract = "Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.",
author = "J Eugen-Olsen and O Andersen and A Linneberg and S Ladelund and {Hansen T}, W and A Langkilde and Janne Petersen and T Pielak and M{\o}ller, {N. L.} and J Jeppesen and S Lyngb{\ae}k and M Fenger and {Olsen M}, H and K Borch-Johnsen and Torben J{\o}rgensen and {Haugaard S}, B and Hildebrandt, {P. R.}",
year = "2010",
doi = "10.1111/j.1365-2796.2010.02252.x",
language = "English",
volume = "268",
pages = "296--308",
journal = "Acta Medica Scandinavica",
issn = "0955-7873",
publisher = "Wiley-Blackwell",
number = "3",
}
RIS
TY - JOUR
T1 - Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
AU - Eugen-Olsen, J
AU - Andersen, O
AU - Linneberg, A
AU - Ladelund, S
AU - Hansen T, W
AU - Langkilde, A
AU - Petersen, Janne
AU - Pielak, T
AU - Møller, N. L.
AU - Jeppesen, J
AU - Lyngbæk, S
AU - Fenger, M
AU - Olsen M, H
AU - Borch-Johnsen, K
AU - Jørgensen, Torben
AU - Haugaard S, B
AU - Hildebrandt, P. R.
PY - 2010
Y1 - 2010
N2 - Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.
AB - Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.
U2 - 10.1111/j.1365-2796.2010.02252.x
DO - 10.1111/j.1365-2796.2010.02252.x
M3 - Journal article
C2 - 20561148
VL - 268
SP - 296
EP - 308
JO - Acta Medica Scandinavica
JF - Acta Medica Scandinavica
SN - 0955-7873
IS - 3
ER -
